Symrise Ag

Imke Meyer

Martina Herrmann

Holger Joppe

Gerhard Schmaus

William Johncock

Gabriele Vielhaber

Jean Krutmann

Oskar Koch

Marielle Le Maire

Dominik Stuhlmann

Claudia Gömann

Mirjam Knupfer

Nadine Hillebrand

Bernd Hölscher

Heiko Oertling

Sabine Lange

Joachim Hans

Benoit Join

Ravikumar Pillai

Marc Mansfeld

Aurélie Trunet

Antje Köhler

Thomas Küper

Rahim Brodhage

Marco Massironi

Karin Schaper

Sebastian Bruncke

Sandro Rosa

Katrina Nielsen

Francesca Benato

Léa Schmidt

Andrew Mcshea

Julia Betke

Helko Oertling

Mareille Le Maire

Claudia GÖMANN

A bacterial ferment obtained by a method including the following steps: (a) culturingspecies in at least one growth medium for at least 24 hours; (b) separating the mixture via centrifugation; (c) adding lactic acid to the supernatant obtained from step b) in an amount sufficient to lower the pH value of the supernatant; (d) stabilizing the resulting mixture with the addition of at least one preservative and/or at least one multifunctional; and optionally (e) filtering the mixture to remove any final precipitation.

Bacterial ferment ofspecies

Suggested is an antimicrobial mixture comprising or consisting of (a) at least one monocyclic sesquiterpene alcohol, (b) at least one active selected from the group consisting of 4-hydroxyacetophenone, sorbitan caprylate, cocamidopropyl PG-dimonium chloride phosphate, tetrasodium glutamate diacetate, glyceryl caprylate and glyceryl caprate, and optionally (c) at least one additional antimicrobial agent different from components (a) and (b).

Antimicrobial mixture

The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Medicament comprising ginger root CO2 extract

Medicament and cosmetic composition comprising resorcinol derivatives

Medicament

Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of purple coneflower pressed juice, sclareolide, ginger root C02 extract, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Cosmetic compositions comprising purple coneflower pressed juice

Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, sclareolide, purple coneflower pressed juice, ginger root CO2 extract or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Cosmetic compositions

Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of ginger root C02 extract, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, sclareolide, purple coneflower pressed juice or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Cosmetic compositions comprising ginger root extracts

Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of sclareolide, ginger root CO2 extract, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, purple coneflower pressed juice or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Cosmetic compositions comprising sclareolide

Suggested is a composition comprising (a) larixol and at least one of the components (b1) to (b5) selected from (b1) tyrosinase inhibitors; (b2) sun protection factors; (b3) antioxidants; (b4) anti-inflammatory agents; and (b5) desquamating agents.

Cosmetic composition for lightening skin and hair

Suggested is a skin or hair whitening mixture, comprising 

Skin and/or hair whitening mixture

The invention relates generally to new compounds of formula (I), wherein R, R', R, R&#x2032;, R, R&#x2032;, RR&#x2032;, R, R&#x2032;, R, Rare independently of one another and denote hydrogen, hydroxyl, Cto C-alkyl group or Rand Rform together a C5-C6 ring system, and wherein n=0, 1, 2, 3, or 4. Moreover, the invention relates to the use of one or more compounds of formula (I) in cosmetic or pharmaceutical compositions, which are preferably dermatological compositions and are preferably used topically. 

Succinate derivatives

Ginger extract compositions containing 25 to 30% b.w. [6]-gingerol, 5 to 10% b.w. [8]-gingerol, 5 to 10% b.w. [10]-gingerol, 1.5 to 4% b.w. [6]-shogaol, 0.3 to 1.3% b.w. [8]-shogaol, 0.03 to 1% b.w. [10]-shogaol and 0.01 to 1% b.w. zingerone, with the amount of gingerols totaling 35 to 50% b.w. and the amount of shogaols totaling 1.5 to 6% b.w.

Ginger extract for the protection of stem cells

This invention relates to cosmetic and pharmaceutical preparations comprising 

Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol

The present invention relates to the cosmetic, dermatological or therapeutic use of certain cyclohexyl carbamate compounds of formula (I) given below, preferably as anti-cellulite actives. The invention further relates to compositions and cosmetic, dermatological or therapeutic products comprising such compounds of formula (I), which are preferably suitable for the prophylaxis (prevention) and cosmetic treatment (combating) of cellulite in human beings, corresponding methods and novel compounds of formula (I) wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl,wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms,B denotes NRR, whereinRdenotes hydrogen or an organic radical having 1 to 14 carbon atoms,Rdenotes an organic radical having 1 to 14 carbon atoms, andwherein optionally Rand Rare covalently bonded to one another, preferably so that B is a 3 to 8 membered ring.

Cyclohexyl carbamate compounds as active anti-cellulite ingredients

Growing community of inventors

Bodenwerder, Germany

Imke Meyer